Cargando…
Changing the daily injection of glatiramer acetate to a monthly long acting product through designing polyester-based polymeric microspheres
[Image: see text] Introduction: Glatiramer acetate (GA) is a newly emerged therapeutic peptide to reduce the frequency of relapses in multiple sclerosis (MS). Despite its good performance in controlling MS, it is not widely used due to daily or biweekly subcutaneous injections due to rapid degradati...
Autores principales: | Molavi, Fatima, Barzegar-Jalali, Mohammad, Hamishehkar, Hamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences (TUOMS Publishing Group)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809140/ https://www.ncbi.nlm.nih.gov/pubmed/36644544 http://dx.doi.org/10.34172/bi.2022.23733 |
Ejemplares similares
-
Bullous pemphigoid as an injection site reaction of glatiramer acetate
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2019) -
Follow-on glatiramer acetate
por: Cohen, Jeffrey A., et al.
Publicado: (2018) -
Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate
por: Vlahova, Lyubomira, et al.
Publicado: (2021) -
29 gauge needles improve patient satisfaction over 27 gauge needles for daily glatiramer acetate injections
por: Glenski, Stephen, et al.
Publicado: (2009) -
Glatiramer acetate in the treatment of multiple sclerosis
por: Tselis, Alex, et al.
Publicado: (2007)